
GC38811
Mcl1-IN-8
Also known as (5Z)-2-[4-(2-hydroxyethyl)piperazin-1-yl]-5-[(4-phenylphenyl)methylidene]-1,3-thiazol-4-one
Mcl1-IN-8 (Compound 8) is an orally active Mcl-1-PUMA interface inhibitor, with a Ki of 0·3 μM· Mcl1-IN-8 exhibits dual activity on reduce PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis in cancer cells
ChemicalCAS678158-55-9MW393.5FormulaC22H23N3O2S
- CAS number
- 678158-55-9
- Molecular weight
- 393.5
- Formula
- C22H23N3O2S
- Solubility
- DMSO: 50 mg/mL (127·06 mM)
- InChIKey
- IBEWMFVUBLAYJT-SILNSSARSA-N
- Catalogue number
- GC38811
- Brand
- GLPBIO
Computed properties PubChem CID 988971 · XLogP 3.2 · TPSA 81.4 Ų · H-bond donors 1
- XLogP
- 3.2
- TPSA
- 81.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 5
- Heavy atoms
- 28
SMILES C1CN(CCN1CCO)C2=NC(=O)/C(=C/C3=CC=C(C=C3)C4=CC=CC=C4)/S2
Computed descriptors from PubChem (CID 988971), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il